MMI Raises $125 Million in Series D Funding to Enhance Microsurgery for Alzheimer's Treatment
- Published
- Source
- leaderobot.com
MMI, a surgical robot company, has successfully secured $125 million in Series D funding. This investment aims to enhance the precision of microsurgery techniques, specifically targeting the treatment of Alzheimer's disease. The funding will enable MMI to advance its technological capabilities and develop innovative solutions in the medical field.
The significance of this funding round lies in its potential to revolutionize how microsurgery is applied in treating complex neurological conditions like Alzheimer's. By leveraging advanced robotics, MMI seeks to improve surgical outcomes and patient care, addressing a critical need in the healthcare sector. This initiative could lead to breakthroughs in the management of Alzheimer's disease, which affects millions worldwide.
Looking ahead, MMI's focus will be on integrating its microsurgery precision technology into clinical practices. The company aims to collaborate with healthcare providers to ensure the effective application of its innovations. No further timeline was disclosed at the time of publication.
Original report
Surgical robot company MMI secures $125 million in Series D funding, aiming to apply microsurgery precision to tackle Alzheimer's disease.
leaderobot.com · LeaderobotThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
-
10
Robotics Summit & Expo 2027 | Jun 2–3, Boston RobotToday · 4 days ago
- 11
- 12
Related Suppliers
MMIST Inc.
Canada
Canadian aerospace and defense firm specializing in GPS-guided precision aerial delivery and recovery systems for military, humanitarian, and commercial uses.
Medical Micro Instruments (MMI)
United States
Creator of the Symani Surgical System, the world's only commercially available robot for microsurgery and supermicrosurgery.
Saronic Technologies
United States
Austin-based defense tech company building autonomous surface vessels for the U.S. Navy, from 6-ft scout drones to 180-ft multi-mission ships.
Mujin 株式会社Mujin
Japan
Japanese robotics software company offering MujinOS, a no-code platform for palletizing, picking, and fleet automation in factories and warehouses.
PARO Robots U.S., Inc.
United States
US distributor of PARO, the FDA-cleared therapeutic seal robot used in dementia and senior care settings.
University of Texas at Arlington — Next Gen Systems & Robotics (UTARI)
United States
Applied R&D institute of UT Arlington, Fort Worth TX, advancing robotics, automation, unmanned systems, biomedical tech, and autonomous vehicles for 30+ years.
Horizon Surgical Systems
United States
UCLA spinout developing the Polaris AI-assisted robotic platform for ophthalmic microsurgery, based in Malibu, California.
Microsure
Netherlands
Dutch medtech founded 2016 by TU Eindhoven and Maastricht UMC; makes MUSA-3, the world's first CE-marked open microsurgery robot assistant.
Cornerstone Robotics
Hong Kong
Hong Kong surgical robotics firm whose Sentire endoscopic system holds CE Mark, Singapore HSA and China NMPA clearance for minimally invasive surgery.
eCential Robotics
France
French surgical robotics company developing an open, unified imaging, navigation, and robotic platform for bone surgery.
Motirka USA Inc (part of Hobart Healthcare)
United States
US subsidiary of Israel's Motorika Medical; markets ReoAmbulator and ReoGo robotic rehabilitation systems for gait and upper-limb neurological therapy.
UCSD Healthcare Robotics Lab
United States
UCSD robotics research lab led by Prof. Laurel Riek; focuses on human-robot teaming, assistive care robots, and healthcare AI in clinical settings.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.
